Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview

214studies shown

Showing 133-144 of 214

Device study icon

CompletedNCT00436020

rTMS in the Treatment of Depression in bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

In Australia

Bipolarity, DepressionDeviceFrom 18 Years to 70 Years

Countries: Australia
Sponsor: Bayside Health
Condition: Bipolarity, Depression

Drug study icon

CompletedNCT03624322

Safety and Tolerability of INP105 (Olanzapine by I231 POD® Device) Nasal Spray in Healthy Volunteers - SNAP 101

This summary needs review. Please check the official study record and contact the research team for details.

In Australia

BipolarityDrugFrom 18 Years to 55 Years

Countries: Australia
Sponsor: Impel Pharmaceuticals
Condition: Bipolarity

Drug study icon

CompletedNCT05304364

Safety, Tolerability, and Pharmacokinetics of Naltrexone Implant (DLP-160)

This study is completed in Australia. It focuses on Addiction.

In Australia

AddictionDrugFrom 18 Years to 50 Years

Countries: Australia
Sponsor: Delpor, Inc.
Condition: Addiction

Drug study icon

CompletedNCT00361543

Selective Estrogen Receptor Modulators - A Potential Treatment for Psychotic Symptoms of Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Australia

SchizophreniaDrugFrom 45 Years to 70 Years

Countries: Australia
Sponsor: The Alfred
Condition: Schizophrenia

Drug study icon

CompletedNCT01481883

Selective Estrogen Receptor Modulators (SERMs) - A Potential Treatment for Psychotic Symptoms of Schizophrenia in Men?

This summary needs review. Please check the official study record and contact the research team for details.

In Australia

SchizophreniaDrugFrom 18 Years to 45 Years

Countries: Australia
Sponsor: The Alfred
Condition: Schizophrenia

Drug study icon

CompletedNCT02354001

Selective Estrogen Receptor Modulators for Women of Child-bearing Age With Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Australia

SchizophreniaDrugFrom 18 Years to 45 Years

Countries: Australia
Sponsor: The Alfred
Condition: Schizophrenia

Behavioral study icon

CompletedNCT02474524

Self-Management and Recovery Technology Psychosocial Intervention study

This summary needs review. Please check the official study record and contact the research team for details.

In Australia

SchizophreniaBehavioralFrom 18 Years to 65 Years

Countries: Australia
Sponsor: Swinburne University of Technology
Condition: Schizophrenia

Drug study icon

CompletedNCT00119652

Seroquel in Depression in bipolarity Versus SSRI

This summary needs review. Please check the official study record and contact the research team for details.

In Australia

Bipolarity, DepressionDrugFrom 18 Years to 65 Years

Countries: United States, Australia, Chile, ...
Sponsor: AstraZeneca
Condition: Bipolarity, Depression

Drug study icon

CompletedNCT00640601

Study Evaluating the Clinical Benefit of SEROQUEL XR in Subjects With Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Australia

SchizophreniaDrugFrom 18 Years to 65 Years

Countries: Australia, Canada, China, ...
Sponsor: AstraZeneca
Condition: Schizophrenia

Drug study icon

CompletedNCT00257972

Aripiprazole in people with Bipolarity type I

This summary needs review. Please check the official study record and contact the research team for details.

In Australia

BipolarityDrugOver 18 Years

Countries: United States, Australia, France, ...
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition: Bipolarity

Drug study icon

CompletedNCT01716975

EVP-6124 (Alpha-7 nAChR) for schizophrenia

This study is completed in the United States, in Australia, in the United Kingdom, .... It is testing EVP-6124 (Alpha-7 nAChR) for schizophrenia.

In Australia

SchizophreniaDrugFrom 18 Years to 50 Years

Countries: United States, Australia, United Kingdom, ...
Sponsor: FORUM Pharmaceuticals Inc
Condition: Schizophrenia

Drug study icon

CompletedNCT01515423

Paliperidone Palmitate 3 Month and 1 Month Formulations for people with Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Australia

SchizophreniaDrugFrom 18 Years to 70 Years

Countries: United States, Australia, France, ...
Sponsor: Janssen Research & Development, LLC
Condition: Schizophrenia

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.